Ten year mortality in relation to original size of myocardial infarct: results from the Gothenburg metoprolol study
- PMID: 8142192
- PMCID: PMC483660
- DOI: 10.1136/hrt.71.3.238
Ten year mortality in relation to original size of myocardial infarct: results from the Gothenburg metoprolol study
Abstract
Objective: To describe the relation between the extent of a myocardial infarct, measured according to maximum serum enzyme activity of lactate dehydrogenase, and mortality at 10 years.
Patients: In 759 patients with acute myocardial infarction in whom serum activity of heat stable lactate dehydrogenase had been determined every 12 hours for 108 hours after randomisation in an early intervention trial with metoprolol.
Main outcome measure: Mortality at 10 years in relation to quartile of maximum serum lactate dehydrogenase activity and history of cardiovascular disease.
Results: Among all patients mortality at 10 years was 39% in the lowest quartile, 51% in the second quartile, 50% in the third, and 59% in the fourth (p < 0.001 for relation between infarct size and 10 year mortality). Among patients without a history of myocardial infarction, angina pectoris, diabetes mellitus, or hypertension the mortality in each quartile was 29%, 32%, 41%, and 56%, respectively (p < 0.001 for relation between infarct size and 10 year mortality). Among patients with any of these risk indicators the association between the estimated infarct size and mortality at 10 years was weak (p < 0.05).
Conclusion: Estimated size of a myocardial infarct and mortality over 10 years seem to be related but mainly in patients without a history of cardiovascular disease.
Similar articles
-
Five-year mortality rate in relation to enzyme-estimated infarct size in acute myocardial infarction.Am Heart J. 1987 Oct;114(4 Pt 1):731-7. doi: 10.1016/0002-8703(87)90782-4. Am Heart J. 1987. PMID: 3310563 Clinical Trial.
-
Ten-year mortality rate after development of acute myocardial infarction in relation to clinical history and observations during hospital stay: experience from the Göteborg metoprolol trial.Coron Artery Dis. 1993 Dec;4(12):1077-83. doi: 10.1097/00019501-199312000-00007. Coron Artery Dis. 1993. PMID: 8162238 Clinical Trial.
-
Correlation between enzymatic estimation of infarct size and early mortality rate.Br Heart J. 1983 Dec;50(6):520-4. doi: 10.1136/hrt.50.6.520. Br Heart J. 1983. PMID: 6651994 Free PMC article. Clinical Trial.
-
Göteborg Metoprolol Trial: enzyme-estimated infarct size.Am J Cardiol. 1984 Jun 25;53(13):15D-21D. Am J Cardiol. 1984. PMID: 6731323 Clinical Trial.
-
Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.Drugs. 1986 May;31(5):376-429. doi: 10.2165/00003495-198631050-00002. Drugs. 1986. PMID: 2940080 Review.
Cited by
-
Pharmacokinetics and safety of a single dose of the novel necrosis inhibitor LC28-0126 in healthy male subjects.Br J Clin Pharmacol. 2017 Jun;83(6):1205-1215. doi: 10.1111/bcp.13213. Epub 2017 Jan 25. Br J Clin Pharmacol. 2017. PMID: 28002882 Free PMC article. Clinical Trial.
-
Early kinetics of serum Interleukine-17A and infarct size in patients with reperfused acute ST-elevated myocardial infarction.PLoS One. 2017 Nov 22;12(11):e0188202. doi: 10.1371/journal.pone.0188202. eCollection 2017. PLoS One. 2017. PMID: 29166391 Free PMC article.
-
Use of carvedilol in hypertension: an update.Vasc Health Risk Manag. 2012;8:307-22. doi: 10.2147/VHRM.S31578. Epub 2012 May 18. Vasc Health Risk Manag. 2012. PMID: 22661898 Free PMC article. Review.
-
Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-α.J Clin Invest. 2020 Mar 2;130(3):1392-1404. doi: 10.1172/JCI99934. J Clin Invest. 2020. PMID: 31985487 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical